DOSE ADJUSTMENT PRACTICES OF PEGINESATIDE VS. EPOETIN IN EMERALD 1 AND 2 PIVOTAL TRIALS
Peginesatide (P) is a synthetic, pegylated, peptide-based ESA approved for treatment of anemia due to chronic kidney disease in adult patients (pts) on dialysis. P demonstrated noninferiority to epoetin (E) in maintenance of Hb levels in hemodialysis (HD) pts in two Phase 3 randomized, active-contro...
Saved in:
Main Authors: | Amit Sharma (Author), Whedy Wang (Author), Alex Yang (Author), Ali Hariri (Author), Hong-Ye Gao (Author), Anne-Marie Duliege (Author), Krishna Polu (Author), Nina Oestreicher (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2012-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estimation of peginesatide utilization requires patient-level data
by: Alex Yang, et al.
Published: (2012) -
Shift in Balance of IV Iron-to-Epoetin USE: 2008-2011
by: Alex Yang, et al.
Published: (2012) -
The Inca Emerald
by: Scoville, Samuel, 1872-; Bull, Charles Livingston, 1874-1932 [Illustrator] -
The Emerald City of Oz
by: Baum, L. Frank (Lyman Frank), 1856-1919 -
The Emerald City of Oz
by: Baum, L. Frank (Lyman Frank), 1856-1919; Neill, John R. (John Rea), 1877-1943 [Illustrator]